breast-cancer

Documents about breast-cancer

• Epigenetic and 3D Genome Changes Drive Primary Trastuzumab Resistance in HER2+ Breast Cancer#230248bioRxiv / medRxiv
• Hypoxia drives trastuzumab resistance through Rac1 pathway in HER2-positive breast cancer#266267bioRxiv / medRxiv
• Mammary SLAMF3 Regulates Store-Operated Ca2+ Entry and Migration Through STIM1 in Breast Cancer Cells and Cell Lines#147577HAL (France)
• A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer#195533ClinicalTrials.gov
• Thematic patterns of social media content by patient-led breast cancer key opinion leaders: A topic modeling study#205426Europe PMC
• Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells#246830HAL (France)
• Evaluation of triple negative breast cancer with heterogeneous immune infiltration#268885IRIS
• A machine learning assay to predict disease recurrence in hormone receptor-positive breast cancer#268887IRIS
• The tumor microenvironment in triple negative breast cancer and a strategy to improve responses to immunotherapy using cryoablation and immunostimulants#273474Europe PMC
• "Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.#290979ClinicalTrials.gov
• Attitudes toward AI-generated risk prediction in patients with early breast cancer: an international multicenter survey#337711IRIS
• Comparing the Effectiveness of Breast Cancer Screening and Diagnostic Tests among Women with Different Breast Densities—The BCSC-ADVANCE Study#1912NCBI Bookshelf
• Safety and Early Outcomes of Immediate Autologous Breast Reconstruction in Advanced Breast Cancer: An Indian Experience.#297204NCBI PubMed Central
• Synergistic Anticancer Activity of Annona muricata Leaf Extract and Cisplatin in 4T1 Triple-Negative Breast Cancer Cells#288169HAL (France)
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors#123552ClinicalTrials.gov
• Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older#208283ClinicalTrials.gov
• Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer#332737ClinicalTrials.gov
• Sleep macro- and microstructure in breast cancer survivors#208783HAL (France)
• Development and pilot feasibility of Kit-CAT, a serious-game-supported consultation for discussing complementary and alternative therapies in breast cancer care#262263HAL (France)
• BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making#337742IRIS
• Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.#348141Lund University Publications
• Exploring the key molecular drivers of lymphovascular invasion in Invasive breast cancer#352406University of Nottingham Repository
• Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer#256904ClinicalTrials.gov
• Temporal dynamics of prognostic factors in breast cancer survival#232906PLOS
• Fear of Cancer Recurrence and Coping in Young Breast Cancer Survivors: A Secondary Analysis.#342366NCBI PubMed Central
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries#6826OpenAlex
• A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies#127579ClinicalTrials.gov
• Physical activity barriers, facilitators, and preferences in primary and tertiary prevention of breast cancer: a French national observational study#68311HAL (France)
• Simultaneous quantification and natural 13C abundance of fatty acids in breast cancer tissues and serum by GC-C-IRMS for tumor characterization#239161HAL (France)
• In-Vitro and In-Silico Study of Anti-Cancer Properties of Methanolic Crude Extract from Cassava (Manihot esculenta Crantz) Leaves on Breast Cancer Cells (MCF-7)#321291Animo Repository
• Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression#125839ClinicalTrials.gov
• IN VIVO CRISPR SCREEN UNCOVERS STAGE-SPECIFIC METABOLIC REPROGRAMMING DURING BREAST CANCER PROGRESSION#292271ScholarBank@NUS
• Accuracy of intraoperative assessment of sentinel lymph nodes in breast cancer patients#316277OpenUCT
• Simulation of a microfluidic device for prolonged cultivation and drug screening of MCF-7 breast cancer cells using COMSOL multiphysics®#366125Animo Repository
• Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.#253008ClinicalTrials.gov
• French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies#350696HAL (France)
• Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial#124635HAL (France)
• Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.#290998ClinicalTrials.gov
• The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person#311141ClinicalTrials.gov
• Subsequent primary cancer incidence among cancer survivors in the United States, 1975–2019: An age–period–cohort analysis#141261PLOS
• Lifestyle, Exercise and Nutrition Study 2 (LEAN 2)#307376ClinicalTrials.gov
• CMV seropositivity associates with poor clinical outcome in triple negative breast cancer#121889HAL (France)
• Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer#238313ClinicalTrials.gov
• From static prediction to dynamic cancer trajectories: Virtual Human Twins for breast cancer decision support.#358212NCBI PubMed Central
• Determinants of patient delay and its association with quality of life among young women with breast cancer in China: A cross-sectional study#5139Europe PMC
• A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer#349923ClinicalTrials.gov
• Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer#18621ClinicalTrials.gov
• AXL-driven stemness and hedgehog signaling in HER2-positive breast cancer with acquired trastuzumab resistance: synergistic potential of AXL and HER2 co-targeting#194877Recep Tayyip Erdoğan University Institutional Repository
• Differences and similarities in breast and colorectal screening participation: a spatial and temporal analysis to reveal intervention areas, France#326021HAL (France)
• Intake of the Total, Classes, and Subclasses of (Poly)phenols and Breast Cancer Risk: A Prospective Analysis of the EPIC Study#11656HAL (France)